Clinically nonfunctioning pituitary tumors are monoclonal in origin
about
Human Pituitary Adenoma Proteomics: New Progresses and PerspectivesPituitary adenomas: historical perspective, surgical management and future directionsMEG3 noncoding RNA: a tumor suppressorThe molecular pathogenesis of pituitary adenomas: an updateSelective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomasGrowth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors.Mechanisms for pituitary tumorigenesis: the plastic pituitary.Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations.Association between p16(CDKN2A) C540G polymorphism and tumor behavior in prolactinoma: A single-center studyThe clonal origin and clonal evolution of epithelial tumours.Genetically engineered mouse models of pituitary tumorsGonadotropin-releasing hormone receptor mRNA expression by human pituitary tumors in vitro.A primary proteomic analysis of serum from patients with nonfunctioning pituitary adenoma.Cellular and molecular specificity of pituitary gland physiology.The pathogenesis of pituitary tumours.Correlations of pituitary tumor transforming gene expression with human pituitary adenomas: a meta-analysis.Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomasClonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe.Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations.Expression profiling of O(6) methylguanine-DNA-methyl transferase in prolactinomas: a correlative study of promoter methylation and pathological features in 136 cases.Pituitary hyperplasia in glycoprotein hormone alpha subunit-, p18(INK4C)-, and p27(kip-1)-null mice: analysis of proteins influencing p27(kip-1) ubiquitin degradationStructure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors.Mammalian Ste20-like kinase 4 promotes pituitary cell proliferation and survival under hypoxia.The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomasTumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.Gene therapy for pituitary tumors.Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors.Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity.Oncogenesis and mutagenesis of pituitary tumors.Pituitary adenomas in childhood: development and diagnosis.Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics.Expression of bcl-2 oncoprotein in pituitary tumours: comparison with c-mycHeparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription.Advances in the Diagnosis, Treatment, and Molecular Genetics of Pituitary Adenomas in Childhood.Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenomaIsolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach.The molecular pathogenesis of corticotroph tumours.Clinicopathological correlations in pituitary adenomas.The role of genetic and epigenetic changes in pituitary tumorigenesis.The effects of age and spontaneous adenoma formation on trophic activity in the rat pituitary gland: a comparison with trophic activity in the human pituitary and in human pituitary adenomas.
P2860
Q26746005-26F5C800-4E08-4F45-A527-438AABE9F916Q26779749-8523D8CF-08D2-45BD-908B-B1F237C3C27DQ26823948-33FC40B4-A1B7-4F22-B560-05AB4E22EE07Q26830047-A2F9FCB6-7D3C-49B4-B28D-C575A1D2B183Q28117410-7FA04FC2-D0CA-44AB-8B3A-4B59C1FE5564Q30445064-29492DD5-6FFC-434F-8343-17C1E6345FA1Q33630319-8211E08A-D85D-450C-A35E-C3DA547F2BBAQ33632000-BEC80210-88D0-43A7-8001-D3194B6662AFQ33733489-A7A3C546-BC31-4F8F-99D1-F152828E87BEQ33890376-E32F6452-1F2C-41F0-AE55-682B10353830Q33984418-465D5183-AA72-47B1-9AD7-3ADEA4369B20Q34150016-C5DF1D4B-312E-4222-B597-198F53C38D2BQ34201571-53280446-9865-4204-913A-D5F92B707FE5Q34251305-48A3B57E-1694-4F16-B399-A8B07CE73C12Q34988259-A35CDD21-1646-4153-A9BA-0A2BB87576B8Q35110682-CB309582-DE78-466D-A322-8CD0DAB403A2Q35235761-2229965C-0522-4266-983D-D9DB180295ABQ35601767-A7E078AC-B0C3-4E01-9998-E08FE53F14F5Q35611768-46A731A3-0EB1-46A9-B3CE-5E39EAC18B79Q35785924-798911E4-FC3F-460E-AE14-9F79551192E8Q35788871-C44A7A10-895E-4067-A0A7-514B7957FF78Q35882946-3DE95E6C-A25E-4403-827B-ECDA89FBEF4AQ36087352-1AE50FAF-17A8-4A6C-81A6-29CF810E411AQ36117662-CFDECE3F-8FF3-4552-918F-FAB6B2C25189Q36161900-0B094779-01A1-476F-977A-BEF9043AD828Q36386450-E09595B1-238B-4B0A-9005-8FF4732236C7Q36467340-13C7491B-B743-4CB9-B31E-D6EF36DF08A0Q36467344-20FC0CB5-8F2F-4FD7-BB8D-8DAAC4BB2B69Q36605354-842D8EEC-00C8-44B0-89E4-5651076B5313Q36909002-DD40B75E-C2F5-4CCB-9514-1636DA5B3DECQ37139774-8388698D-E636-4F75-8C2E-6577CFE54536Q37223929-5A934BED-8933-4872-9E2D-CBBC9BD1002EQ37351307-DA8AE6F0-1C54-40CE-AE94-ECD69E90DAC0Q37425200-5364EFBD-2DA5-48F4-88DD-8C7ADF9B5EF8Q37619445-C1CF832E-FF46-4913-B559-D8278826150EQ37704785-EE8A75B6-1746-4668-8EAD-C8CBAA08B6BEQ37958029-89ED9B6B-8AD5-4BDD-98FA-E415E7DE154CQ38018648-6C8C36FF-2339-4E2D-B482-D2A4E414B056Q38274982-6F40D276-C12D-4278-B58A-D2CE77A05BB0Q38468702-178C17C3-6814-49FF-87F6-FB4F886E578A
P2860
Clinically nonfunctioning pituitary tumors are monoclonal in origin
description
1990 nî lūn-bûn
@nan
1990 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Clinically nonfunctioning pituitary tumors are monoclonal in origin
@ast
Clinically nonfunctioning pituitary tumors are monoclonal in origin
@en
Clinically nonfunctioning pituitary tumors are monoclonal in origin
@nl
type
label
Clinically nonfunctioning pituitary tumors are monoclonal in origin
@ast
Clinically nonfunctioning pituitary tumors are monoclonal in origin
@en
Clinically nonfunctioning pituitary tumors are monoclonal in origin
@nl
prefLabel
Clinically nonfunctioning pituitary tumors are monoclonal in origin
@ast
Clinically nonfunctioning pituitary tumors are monoclonal in origin
@en
Clinically nonfunctioning pituitary tumors are monoclonal in origin
@nl
P2093
P2860
P356
P1476
Clinically nonfunctioning pituitary tumors are monoclonal in origin
@en
P2093
A Klibanski
B M Biller
J M Alexander
N T Zervas
P2860
P304
P356
10.1172/JCI114705
P407
P577
1990-07-01T00:00:00Z